Literature DB >> 2646321

Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.

S Ramakrishnan1, F J Xu, S J Brandt, J E Niedel, R C Bast, E L Brown.   

Abstract

Many nonhematologic tumors produce growth factors that may influence cellular proliferation either by autocrine or by paracrine mechanisms. In the current study, human tumor cell lines were investigated for the constitutive production of macrophage colony-stimulating factor (M-CSF). Culture supernatants obtained from cell lines were analyzed using a radioimmunoassay and a radioreceptor assay specific for M-CSF. Among the various cell types analyzed, all the ovarian cell lines and a majority of the breast cancer cell lines secreted significant amount of an M-CSF-like factor. Treatment of mouse bone marrow cultures with culture supernatants from ovarian cancer cells stimulated the production of macrophage colonies. Analysis of total cellular RNA obtained from the ovarian cell lines by Northern blot showed multiple sizes of M-CSF transcripts with an abundance of a 4.2-kb message. The relative amount of M-CSF transcripts correlated with the level of immunoreactive material seen in the culture supernatants.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646321      PMCID: PMC303767          DOI: 10.1172/JCI113977

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Cultivation of human breast carcinomas.

Authors:  E Y LASFARGUES; L OZZELLO
Journal:  J Natl Cancer Inst       Date:  1958-12       Impact factor: 13.506

2.  A new technique for the cytochemical examination of human hemopoietic cells grown in agar gel.

Authors:  K Kubota; H Mizoguchi; Y Miura; T Suda; F Takaku
Journal:  Exp Hematol       Date:  1980-03       Impact factor: 3.084

Review 3.  The molecular genetics of cellular oncogenes.

Authors:  H E Varmus
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

4.  In vitro growth stimulation of human ovarian cancer cells by xenogeneic peritoneal macrophages.

Authors:  C E Welander; R B Natale; J L Lewis
Journal:  J Natl Cancer Inst       Date:  1982-11       Impact factor: 13.506

5.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

6.  Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors.

Authors:  J S Huang; S S Huang; T F Deuel
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

7.  Clear cell carcinoma of the ovary with colony-stimulating-factor production. Occurrence of marked granulocytosis in a patient and nude mice.

Authors:  A Takeda; K Suzumori; Y Sugimoto; Y Yagami; T Miyazawa; C Yamada; M Matsuyama
Journal:  Cancer       Date:  1984-09-15       Impact factor: 6.860

8.  The chromosomal basis of human neoplasia.

Authors:  J J Yunis
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

9.  Human transforming growth factor. Production by a melanoma cell line, purification, and initial characterization.

Authors:  H Marquardt; G J Todaro
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

10.  Reactivity of a monoclonal antibody with human ovarian carcinoma.

Authors:  R C Bast; M Feeney; H Lazarus; L M Nadler; R B Colvin; R C Knapp
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  22 in total

1.  Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter.

Authors:  L F Lee; J S Haskill; N Mukaida; K Matsushima; J P Ting
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 2.  The macrophage growth factor CSF-1 in mammary gland development and tumor progression.

Authors:  Elaine Y Lin; Valerie Gouon-Evans; Andrew V Nguyen; Jeffrey W Pollard
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

3.  Interleukin-6 and renal cell cancer: production, regulation, and growth effects.

Authors:  A S Koo; C Armstrong; B Bochner; T Shimabukuro; C L Tso; J B deKernion; A Belldegrum
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.

Authors:  S M Scholl; R Lidereau; A de la Rochefordière; C C Le-Nir; V Mosseri; C Noguès; P Pouillart; F R Stanley
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.

Authors:  M R Young; M A Wright; M E Young
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 6.  Macrophage colony-stimulating factor and cancer: a review.

Authors:  S Chockalingam; Siddhartha Sankar Ghosh
Journal:  Tumour Biol       Date:  2014-09-20

7.  Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.

Authors:  B M Kacinski; D Carter; K Mittal; L D Yee; K A Scata; L Donofrio; S K Chambers; K I Wang; T Yang-Feng; L R Rohrschneider
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

Review 8.  Role of CSF-1 in progression of epithelial ovarian cancer.

Authors:  Setsuko K Chambers
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

9.  Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma.

Authors:  Dae Sung Cho; Se Joong Kim; Soo Hyung Lee; Hyun Soo Ahn; Young Soo Kim; Sun Il Kim
Journal:  Korean J Urol       Date:  2011-02-21

Review 10.  Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Authors:  R Clarke
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.